指南与共识免疫规划

麻疹疫苗:世界卫生组织立场文件,2017年4月——建议

Measles vaccines: WHO position paper, April 2017 - Recommendations.
指南 / 共识 · Vaccine · 2017-07-29

本文呈现世界卫生组织(WHO)关于麻疹疫苗使用的建议,摘自2017年4月发布的WHO麻疹疫苗立场文件,该文件替代2009年版本。文件总结了麻疹领域最新进展,包括取消常规第二剂麻疹成分疫苗(MCV2)的引入标准、6月龄婴儿接种指导以及接受高效抗逆转录病毒治疗(HAART)的HIV感染儿童再接种指导。

要点

  • WHO立场文件取消常规第二剂麻疹成分疫苗(MCV2)的引入标准。
  • 文件提供6月龄婴儿接种麻疹疫苗的指导。
  • 文件提供接受HAART的HIV感染儿童再接种麻疹疫苗的指导。

核心结论

  • WHO发布2017年4月麻疹疫苗立场文件,替代2009年立场文件,提出取消MCV2引入标准、6月龄婴儿接种指导及HIV感染儿童再接种指导。

研究设计与样本

  • WHO立场文件,基于2013年11月、2015年10月和2016年10月免疫战略咨询专家组(SAGE)会议讨论的证据制定。

主要发现

  • 立场文件总结了麻疹领域最新进展,包括取消常规第二剂麻疹成分疫苗(MCV2)的引入标准、6月龄婴儿接种指导以及接受HAART的HIV感染儿童再接种指导。

关键数值与推荐

  • 取消常规第二剂麻疹成分疫苗(MCV2)的引入标准。
  • 提供6月龄婴儿接种麻疹疫苗的指导。
  • 提供接受HAART的HIV感染儿童再接种麻疹疫苗的指导。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This article presents the World Health Organization's (WHO) recommendations on the use of measles vaccines excerpted from the WHO position paper on Measles vaccines: WHO position paper - April 2017, published in the Weekly Epidemiological Record [1]. This position paper replaces the 2009 WHO position paper on measles vaccines [2]. The position paper summarizes the most recent developments in the field of measles and includes removal of introduction criteria for the routine second dose of measles-containing vaccine (MCV2), guidance on when to vaccinate infants from 6months of age, and guidance on re-vaccination of HIV-infected children receiving highly active anti-retroviral therapy (HAART). Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence, and to the evidence-to-recommendation table. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of measles vaccines were discussed by SAGE in November 2013, October 2015 and October 2016; evidence presented at these meetings can be accessed at: www.who.int/immunization/sage/meetings/2013/november/presentations_background_docs/en/, www.who.int/immunization/sage/meetings/2015/october/presentations_background_docs/en/ and www.who.int/immunization/sage/meetings/2016/october/presentations_background_docs/en/.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. World Health Organization. Measles vaccines: WHO position paper, April 2017 - Recommendations. Vaccine. 2017. PMID: 28760612. doi:10.1016/j.vaccine.2017.07.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。